Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
ACADIA Pharmaceuticals, Inc.
Pharmaceutical Preparations CA, United States
Nasdaq: ACAD
Company Description
ACADIA Pharmaceuticals, Inc. focuses on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. It is developing a portfolio consisting of four advanced product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson's disease psychosis and retained worldwide commercialization rights to pimavanserin. It also has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma. ACADIA Pharmaceuticals was founded on July 16, 1993 and is headquartered in San Diego, CA.
Similar to: Trius Therapeutics, Inc., AstraZeneca Plc, NPS Pharmaceuticals, Inc.
Featured Company
Fidelity China Special Situations Plc
Surrey, SU, GB
Fidelity China Special Situations Plc is an investment trust with the interest in investments in equities, index linked, equity linked,… Learn more →
Social Monitor
You may also be interested in:
NPS Pharmaceuticals, Inc.
Bedminster, NJ, US
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →
AstraZeneca Plc
London, LO, GB
AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →
Trius Therapeutics, Inc.
San Diego, CA, US
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics… Learn more →